|
1
|
Pazhouhi M, Sariri R, Rabzia A and Khazaei
M: Thymoquinone synergistically potentiates temozolomide
cytotoxicity through the inhibition of autophagy in U87MG cell
line. Iran J Basic Med Sci. 19:890–898. 2016.PubMed/NCBI
|
|
2
|
Bak DH, Kang SH, Choi DR, Gil MN, Yu KS,
Jeong JH, Lee NS, Lee JH, Jeong YG, Kim DK, et al: Autophagy
enhancement contributes to the synergistic effect of vitamin D in
temozolomide-based glioblastoma chemotherapy. Exp Ther Med.
11:2153–2162. 2016.PubMed/NCBI
|
|
3
|
Safari M and Khoshnevisan A: Cancer stem
cells and chemo-resistance in glioblastoma multiform: A review
article. J Stem Cells. 10:271–285. 2015.
|
|
4
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al European Organisation for Research and Treatment of Cancer
Brain Tumor and Radiotherapy Groups; National Cancer Institute of
Canada Clinical Trials Group: Radiotherapy plus concomitant and
adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park D and Yoon M: Compound K, a novel
ginsenoside metabolite, inhibits adipocyte differentiation in
3T3-L1 cells: Involvement of angiogenesis and MMPs. Biochem Biophys
Res Commun. 422:263–267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Attele AS, Wu JA and Yuan CS: Ginseng
pharmacology: Multiple constituents and multiple actions. Biochem
Pharmacol. 58:1685–1693. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cho CW, Kim YC, Kang JH, Rhee YK, Choi SY,
Kim KT, Lee YC and Hong HD: Characteristic study on the chemical
components of Korean curved ginseng products. J Ginseng Res.
37:349–354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo J, Chang L, Zhang X, Pei S, Yu M and
Gao J: Ginsenoside compound K promotes β-amyloid peptide clearance
in primary astrocytes via autophagy enhancement. Exp Ther Med.
8:1271–1274. 2014.PubMed/NCBI
|
|
9
|
Qi LW, Wang CZ, Du GJ, Zhang ZY, Calway T
and Yuan CS: Metabolism of ginseng and its interactions with drugs.
Curr Drug Metab. 12:818–822. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li W, Zhang M, Gu J, Meng ZJ, Zhao LC,
Zheng YN, Chen L and Yang GL: Hypoglycemic effect of
protopanaxadiol-type ginsenosides and compound K on Type 2 diabetes
mice induced by high-fat diet combining with streptozotocin via
suppression of hepatic gluconeogenesis. Fitoterapia. 83:192–198.
2012. View Article : Google Scholar
|
|
11
|
Kim DY, Yuan HD, Chung IK and Chung SH:
Compound K, intestinal metabolite of ginsenoside, attenuates
hepatic lipid accumulation via AMPK activation in human hepatoma
cells. J Agric Food Chem. 57:1532–1537. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim K, Park M, Lee YM, Rhyu MR and Kim HY:
Ginsenoside metabolite compound K stimulates glucagon-like
peptide-1 secretion in NCI-H716 cells via bile acid receptor
activation. Arch Pharm Res. 37:1193–1200. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Akao T, Kanaoka M and Kobashi K:
Appearance of compound K, a major metabolite of ginsenoside Rb1 by
intestinal bacteria, in rat plasma after oral administration -
measurement of compound K by enzyme immunoassay. Biol Pharm Bull.
21:245–249. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shin KO, Seo CH, Cho HH, Oh S, Hong SP,
Yoo HS, Hong JT, Oh KW and Lee YM: Ginsenoside compound K inhibits
angiogenesis via regulation of sphingosine kinase-1 in human
umbilical vein endothelial cells. Arch Pharm Res. 37:1183–1192.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hasegawa H, Sung JH and Huh JH: Ginseng
intestinal bacterial metabolite IH901 as a new anti-metastatic
agent. Arch Pharm Res. 20:539–544. 1997. View Article : Google Scholar
|
|
16
|
Zhang K and Li Y: Effects of ginsenoside
compound K combined with cisplatin on the proliferation, apoptosis
and epithelial mesenchymal transition in MCF-7 cells of human
breast cancer. Pharm Biol. 54:561–568. 2016. View Article : Google Scholar
|
|
17
|
Kang KA, Piao MJ, Kim KC, Zheng J, Yao CW,
Cha JW, Kim HS, Kim DH, Bae SC and Hyun JW: Compound K, a
metabolite of ginseng saponin, inhibits colorectal cancer cell
growth and induces apoptosis through inhibition of histone
deacetylase activity. Int J Oncol. 43:1907–1914. 2013.PubMed/NCBI
|
|
18
|
Zhang Z, Du GJ, Wang CZ, Wen XD, Calway T,
Li Z, He TC, Du W, Bissonnette M, Musch MW, et al: Compound K, a
ginsenoside metabolite, inhibits colon cancer growth via multiple
pathways including p53-p21 interactions. Int J Mol Sci.
14:2980–2995. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng ZZ, Ming YL, Chen LH, Zheng GH, Liu
SS and Chen QX: Compound K-induced apoptosis of human
hepatocellular carcinoma MHCC97-H cells in vitro. Oncol Rep.
32:325–331. 2014.PubMed/NCBI
|
|
20
|
Aroui S, Aouey B, Chtourou Y, Meunier AC,
Fetoui H and Kenani A: Naringin suppresses cell metastasis and the
expression of matrix metalloproteinases (MMP-2 and MMP-9) via the
inhibition of ERK-38-JNK signaling pathway in human glioblastoma.
Chem Biol Interact. 244:195–203. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zou M, Zhang X and Xu C: IL6-induced
metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of
3,3′-diindolyl-methane in ovarian cancer cells. Cell Oncol (Dordr).
39:47–57. 2016. View Article : Google Scholar
|
|
22
|
Yang N, Hui L, Wang Y, Yang H and Jiang X:
SOX2 promotes the migration and invasion of laryngeal cancer cells
by induction of MMP-2 via the PI3K/Akt/mTOR pathway. Oncol Rep.
31:2651–2659. 2014.PubMed/NCBI
|
|
23
|
Chen BB, Glasser JR, Coon TA and
Mallampalli RK: F-box protein FBXL2 exerts human lung tumor
suppressor-like activity by ubiquitin-mediated degradation of
cyclin D3 resulting in cell cycle arrest. Oncogene. 31:2566–2579.
2012. View Article : Google Scholar
|
|
24
|
Lin JT, Li HY, Chang NS, Lin CH, Chen YC
and Lu PJ: WWOX suppresses prostate cancer cell progression through
cyclin D1-mediated cell cycle arrest in the G1 phase. Cell Cycle.
14:408–416. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qian C, Wang JQ, Song CL, Wang LL, Ji LN
and Chao H: The induction of mitochondria-mediated apoptosis in
cancer cells by ruthenium(II) asymmetric complexes. Metallomics.
5:844–854. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chou YC, Chang MY, Wang MJ, Harnod T, Hung
CH, Lee HT, Shen CC and Chung JG: PEITC induces apoptosis of Human
Brain Glioblastoma GBM8401 Cells through the extrinsic- and
intrinsic signaling pathways. Neurochem Int. 81:32–40. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ray T, Chakrabarti MK and Pal A:
Hemagglutinin protease secreted by V. cholerae induced apoptosis in
breast cancer cells by ROS mediated intrinsic pathway and regresses
tumor growth in mice model. Apoptosis. 21:143–154. 2016. View Article : Google Scholar
|
|
28
|
Liu Y, Jiao R, Ma ZG, Liu W, Wu QQ, Yang
Z, Li FF, Yuan Y, Bian ZY and Tang QZ: Sanguinarine inhibits
angiotensin II-induced apoptosis in H9c2 cardiac cells via
restoring reactive oxygen species-mediated decreases in the
mitochondrial membrane potential. Mol Med Rep. 12:3400–3408.
2015.PubMed/NCBI
|
|
29
|
Yu XS, Du J, Fan YJ, Liu FJ, Cao LL, Liang
N, Xu DG and Zhang JD: Activation of endoplasmic reticulum stress
promotes autophagy and apoptosis and reverses chemoresistance of
human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR
signaling pathway. Oncotarget. 7:76827–76839. 2016.PubMed/NCBI
|
|
30
|
Bischof J, Westhoff MA, Wagner JE,
Halatsch ME, Trentmann S, Knippschild U, Wirtz CR and Burster T:
Cancer stem cells: The potential role of autophagy, proteolysis,
and cathepsins in glioblastoma stem cells. Tumour Biol.
39:10104283176922272017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jung EH, Lee HN, Han GY, Kim MJ and Kim
CW: Targeting ROR1 inhibits the self-renewal and invasive ability
of glioblastoma stem cells. Cell Biochem Funct. 34:149–157. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo Y, Liu S, Wang P, Zhao S, Wang F, Bing
L, Zhang Y, Ling EA, Gao J and Hao A: Expression profile of
embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human
gliomas. Histopathology. 59:763–775. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim H, Roh HS, Kim JE, Park SD, Park WH
and Moon JY: Compound K attenuates stromal cell-derived growth
factor 1 (SDF-1)-induced migration of C6 glioma cells. Nutr Res
Pract. 10:259–264. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Choi K, Kim M, Ryu J and Choi C:
Ginsenosides compound K and Rh2 inhibit tumor necrosis
factor-alpha-induced activation of the NF-kappaB and JNK pathways
in human astroglial cells. Neurosci Lett. 421:37–41. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang XD, Yang YY, Ouyang DS and Yang GP: A
review of biotransformation and pharmacology of ginsenoside
compound K. Fitoterapia. 100:208–220. 2015. View Article : Google Scholar
|
|
36
|
Gutschalk CM, Yanamandra AK, Linde N,
Meides A, Depner S and Mueller MM: GM-CSF enhances tumor invasion
by elevated MMP-2, -9, and -26 expression. Cancer Med. 2:117–129.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kalhori V and Törnquist K: MMP2 and MMP9
participate in S1P-induced invasion of follicular ML-1 thyroid
cancer cells. Mol Cell Endocrinol. 404:113–122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chou YC, Chang MY, Wang MJ, Yu FS, Liu HC,
Harnod T, Hung CH, Lee HT and Chung JG: PEITC inhibits human brain
glioblastoma GBM 8401 cell migration and invasion through the
inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and
-9 gene expression. Oncol Rep. 34:2489–2496. 2015.PubMed/NCBI
|
|
39
|
Lathia JD, Mack SC, Mulkearns-Hubert EE,
Valentim CL and Rich JN: Cancer stem cells in glioblastoma. Genes
Dev. 29:1203–1217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cho DY, Lin SZ, Yang WK, Lee HC, Hsu DM,
Lin HL, Chen CC, Liu CL, Lee WY and Ho LH: Targeting cancer stem
cells for treatment of glioblastoma multiforme. Cell Transplant.
22:731–739. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cruceru ML, Neagu M, Demoulin JB and
Constantinescu SN: Therapy targets in glioblastoma and cancer stem
cells: Lessons from haematopoietic neoplasms. J Cell Mol Med.
17:1218–1235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gatti M, Pattarozzi A, Bajetto A, Würth R,
Daga A, Fiaschi P, Zona G, Florio T and Barbieri F: Inhibition of
CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human
glioblastoma stem-like cells affecting self-renewal activity.
Toxicology. 314:209–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ashizawa T, Miyata H, Iizuka A, Komiyama
M, Oshita C, Kume A, Nogami M, Yagoto M, Ito I, Oishi T, et al:
Effect of the STAT3 inhibitor STX-0119 on the proliferation of
cancer stem-like cells derived from recurrent glioblastoma. Int J
Oncol. 43:219–227. 2013.PubMed/NCBI
|
|
44
|
Kim B, Jung N, Lee S, Sohng JK and Jung
HJ: Apigenin inhibits cancer stem cell-like phenotypes in human
glioblastoma cells via suppression of c-Met signaling. Phytother
Res. 30:1833–1840. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Safa AR, Saadatzadeh MR, Cohen-Gadol AA,
Pollok KE and Bijangi-Vishehsaraei K: Emerging targets for
glioblastoma stem cell therapy. J Biomed Res. 30:19–31. 2015.
|
|
46
|
Oh J and Kim JS: Compound K derived from
ginseng: Neuroprotection and cognitive improvement. Food Funct.
7:4506–4515. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ye R, Zhang X, Kong X, Han J, Yang Q,
Zhang Y, Chen Y, Li P, Liu J, Shi M, et al: Ginsenoside Rd
attenuates mitochondrial dysfunction and sequential apoptosis after
transient focal ischemia. Neuroscience. 178:169–180. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kang KA, Kim HS, Kim DH and Hyun JW: The
role of a ginseng saponin metabolite as a DNA methyltransferase
inhibitor in colorectal cancer cells. Int J Oncol. 43:228–236.
2013.PubMed/NCBI
|
|
49
|
Dougherty U, Mustafi R, Wang Y, Musch MW,
Wang CZ, Konda VJ, Kulkarni A, Hart J, Dawson G, Kim KE, et al:
American ginseng suppresses Western diet-promoted tumorigenesis in
model of inflammation-associated colon cancer: Role of EGFR. BMC
Complement Altern Med. 11:1112011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Choi HH, Jong HS, Park JH, Choi S, Lee JW,
Kim TY, Otsuki T, Namba M and Bang YJ: A novel ginseng saponin
metabolite induces apoptosis and down-regulates fibroblast growth
factor receptor 3 in myeloma cells. Int J Oncol. 23:1087–1093.
2003.PubMed/NCBI
|
